Samsara BioCapital’s Surrozen SRZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.16M | Hold |
241,400
| – | – | 0.44% | 21 |
|
|
2025
Q1 | $2.81M | Buy |
+241,400
| New | +$2.81M | 0.5% | 21 |
|
|
2023
Q2 | – | Sell |
-20,000
| Closed | -$181K | – | 53 |
|
|
2023
Q1 | $181K | Hold |
20,000
| – | – | 0.04% | 51 |
|
|
2022
Q4 | $175K | Hold |
20,000
| – | – | 0.04% | 50 |
|
|
2022
Q3 | $606K | Hold |
20,000
| – | – | 0.14% | 47 |
|
|
2022
Q2 | $900K | Hold |
20,000
| – | – | 0.24% | 44 |
|
|
2022
Q1 | $903K | Hold |
20,000
| – | – | 0.23% | 46 |
|
|
2021
Q4 | $1.93M | Hold |
20,000
| – | – | 0.37% | 36 |
|
|
2021
Q3 | $2.12M | Buy |
+20,000
| New | +$2.12M | 0.33% | 36 |
|